Orgill | Business Facilities - Area Economic Development, Site Selection & Workforce Solutions

Orgill, Inc. will invest $15 million to build a new 100,000-square-foot world headquarters facility in east Shelby County, TN, creating 115 new jobs.


https://businessfacilities.com/2015/11/orgill-inc-to-build-new-15m-hq-in-shelby-county-tn/
Orgill, Inc. will invest $15 million to build a new 100,000-square-foot world headquarters facility in east Shelby County, TN, creating 115 new jobs.

Orgill

Economic development creates opportunities to grow state, local and metro areas, which are essential for economic growth, improved quality of life and community development. Orgill articles below.


Orgill, Inc. To Build New $15M HQ In Shelby County, TN

Orgill, Inc. will invest $15 million to build a new 100,000-square-foot world headquarters facility in east Shelby County, TN, creating 115 new jobs.

Business Facilities & COVID-19

Michigan Governor’s Report: Standing Tall At The Crossroads Of Calamity

When a foreign pandemic invaded Michigan a year ago—and a virulent domestic pathogen threatened to topple the state government—Governor Gretchen Whitmer stood her ground.

Life Sciences Hubs: Good Genes, GREAT Growth

Billions in private equity and public funding are flowing into the life sciences sector, which is front and center in the battle against the pandemic.

Stay Connected

636FansLike
40,000FollowersFollow
3,221FollowersFollow
50SubscribersSubscribe

Business Facilities Featured Location Spotlight

Location Spotlight: Topeka, Kansas

With three top universities in the area and connectivity via major interstates, Topeka, Kansas is rich with opportunity. Visit the GO Topeka Economic Partnership to learn more.

Business Facilities Featured Location Videos

BF Location Video: REDI East Texas Logistics Center

AR-TX REDI, Texarkana’s regional economic development organization, is home to the REDI East Texas Logistics Center. The 850-acre site is publicly owned and controlled by AR-TX REDI, offering short development timelines with no risk. Learn more.